Too Heng-Phon

Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore.

Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore.

MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore.